September 10, 2018 / 6:37 AM / 14 days ago

Consort and Opiant to work on nasal spray overdose treatment

Sept 10 (Reuters) - Consort Medical Plc has agreed to develop a nasal spray for treating opioid overdoses with specialty pharmaceutical company Opiant Pharmaceuticals Inc .

Opiant earlier this year was awarded a $7.4 million grant by the National Institutes of Health's National Institute on Drug Abuse (NIDA) for the development of a nasally-applied version of overdose treatment nalmefene. (Reporting by Noor Zainab Hussain in Bengaluru; editing by Patrick Graham)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below